tiprankstipranks
CSPC Pharmaceutical Group Limited (HK:1093)
:1093
Hong Kong Market
1093
CSPC Pharmaceutical Group
RESEARCH TOOLSreports
Want to see HK:1093 full AI Analyst Report?

CSPC Pharmaceutical Group (1093) Ratios

30 Followers

CSPC Pharmaceutical Group Ratios

HK:1093's free cash flow for Q4 2025 was HK$0.66. For the 2025 fiscal year, HK:1093's free cash flow was decreased by HK$ and operating cash flow was HK$0.11. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
 2.19 2.19 2.27 2.63 2.38
Quick Ratio
 1.88 1.88 1.95 2.32 2.13
Cash Ratio
 0.60 0.60 0.66 1.18 1.16
Solvency Ratio
 0.42 0.42 0.52 0.62 0.66
Operating Cash Flow Ratio
 0.58 0.58 0.44 0.41 0.92
Short-Term Operating Cash Flow Coverage
 12.92 12.80 11.56 9.28 53.11
Net Current Asset Value
HK$ 11.25BHK$ 11.25BHK$ 12.09BHK$ 15.48BHK$ 12.89B
Leverage Ratios
Debt-to-Assets Ratio
 0.01 0.01 0.01 0.01 0.02
Debt-to-Equity Ratio
 0.02 0.02 0.01 0.02 0.02
Debt-to-Capital Ratio
 0.02 0.02 0.01 0.02 0.02
Long-Term Debt-to-Capital Ratio
 0.00 0.00 0.00 0.00 <0.01
Financial Leverage Ratio
 1.41 1.41 1.38 1.39 1.40
Debt Service Coverage Ratio
 9.81 8.70 13.57 15.27 37.63
Interest Coverage Ratio
 102.72 102.89 124.82 270.52 278.45
Debt to Market Cap
 <0.01 <0.01 <0.01 <0.01 <0.01
Interest Debt Per Share
 0.07 0.07 0.05 0.06 0.06
Net Debt to EBITDA
 -0.94 -1.04 -0.87 -1.32 -1.24
Profitability Margins
Gross Profit Margin
65.59%65.59%69.97%70.51%71.94%
EBIT Margin
17.45%15.27%19.69%23.75%24.64%
EBITDA Margin
22.87%20.69%24.30%27.29%28.02%
Operating Profit Margin
15.23%15.27%18.45%22.26%21.94%
Pretax Profit Margin
18.44%18.49%19.23%23.50%24.51%
Net Profit Margin
14.89%14.93%14.92%18.68%19.69%
Continuous Operations Profit Margin
14.86%14.91%14.96%19.31%20.14%
Net Income Per EBT
80.73%80.74%77.58%79.48%80.34%
EBT Per EBIT
121.08%121.08%104.21%105.55%111.71%
Return on Assets (ROA)
8.07%8.09%9.33%11.54%14.89%
Return on Equity (ROE)
11.96%11.39%12.84%16.09%20.89%
Return on Capital Employed (ROCE)
10.56%10.59%14.74%17.20%21.86%
Return on Invested Capital (ROIC)
8.40%8.43%11.33%15.69%17.78%
Return on Tangible Assets
8.63%8.65%9.93%12.12%15.70%
Earnings Yield
4.36%4.37%7.85%6.82%6.37%
Efficiency Ratios
Receivables Turnover
 2.65 2.65 2.97 2.90 4.20
Payables Turnover
 2.93 2.93 3.39 3.27 4.41
Inventory Turnover
 2.82 2.82 2.66 2.96 3.47
Fixed Asset Turnover
 1.88 1.88 2.12 2.70 2.68
Asset Turnover
 0.54 0.54 0.63 0.62 0.76
Working Capital Turnover Ratio
 2.17 2.13 2.00 2.07 2.11
Cash Conversion Cycle
 142.49 142.46 152.34 137.35 109.43
Days of Sales Outstanding
 137.67 137.63 122.80 125.67 87.00
Days of Inventory Outstanding
 129.52 129.49 137.07 123.46 105.21
Days of Payables Outstanding
 124.70 124.67 107.53 111.78 82.77
Operating Cycle
 267.19 267.12 259.87 249.13 192.20
Cash Flow Ratios
Operating Cash Flow Per Share
 0.58 0.57 0.39 0.35 0.77
Free Cash Flow Per Share
 0.39 0.39 0.16 0.19 0.56
CapEx Per Share
 0.19 0.19 0.23 0.16 0.22
Free Cash Flow to Operating Cash Flow
 0.68 0.68 0.41 0.55 0.72
Dividend Paid and CapEx Coverage Ratio
 1.36 1.36 0.73 0.85 1.96
Capital Expenditure Coverage Ratio
 3.09 3.09 1.69 2.21 3.54
Operating Cash Flow Coverage Ratio
 9.28 9.20 8.94 5.91 13.99
Operating Cash Flow to Sales Ratio
 0.24 0.23 0.15 0.13 0.29
Free Cash Flow Yield
1.55%4.61%3.31%2.65%6.78%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 23.08 22.87 12.73 14.67 15.71
Price-to-Sales (P/S) Ratio
 3.40 3.41 1.90 2.74 3.09
Price-to-Book (P/B) Ratio
 2.62 2.61 1.63 2.36 3.28
Price-to-Free Cash Flow (P/FCF) Ratio
 21.40 21.69 30.23 37.71 14.76
Price-to-Operating Cash Flow Ratio
 14.62 14.67 12.37 20.63 10.59
Price-to-Earnings Growth (PEG) Ratio
 0.23 -15.64 -0.53 -2.85 1.19
Price-to-Fair Value
 2.62 2.61 1.63 2.36 3.28
Enterprise Value Multiple
 13.93 15.46 6.94 8.72 9.80
Enterprise Value
 89.42B 90.23B 49.84B 74.88B 86.73B
EV to EBITDA
 13.87 15.46 6.94 8.72 9.80
EV to Sales
 3.17 3.20 1.69 2.38 2.75
EV to Free Cash Flow
 60.26 20.32 26.86 32.76 13.10
EV to Operating Cash Flow
 13.03 13.74 10.99 17.92 9.40
Tangible Book Value Per Share
 3.05 3.08 2.83 3.14 2.38
Shareholders’ Equity Per Share
 3.21 3.23 2.92 3.08 2.50
Tax and Other Ratios
Effective Tax Rate
 0.19 0.19 0.22 0.18 0.18
Revenue Per Share
 2.45 2.47 2.52 2.65 2.65
Net Income Per Share
 0.36 0.37 0.38 0.50 0.52
Tax Burden
 0.81 0.81 0.78 0.79 0.80
Interest Burden
 1.06 1.21 0.98 0.99 0.99
Research & Development to Revenue
 0.22 0.22 0.18 0.15 0.13
SG&A to Revenue
 0.28 0.28 0.34 0.00 0.00
Stock-Based Compensation to Revenue
 <0.01 0.00 <0.01 <0.01 <0.01
Income Quality
 1.64 1.56 0.98 0.57 1.30
Currency in HKD